Given the pivotal role of epithelial–mesenchymal transition (EMT) in the invasion and metastasis of glioma [24], we treated LN229 and U251 cells with CM from NFE2L1‐deficient macrophages. The gene discussed is NFE2L1; the disease is central nervous system cancer.